What is Preoperative or Neoadjuvant Therapy treatment for Breast Cancer?
Preoperative or neoadjuvant therapy is provided before surgery. The aim of preoperative therapy is to reduce the size of the tumor in the breast or lymph node so a surgery is possible or more successful. The type of drugs you get for preoperative therapy is decided based on the subtype of your breast cancer that is determined by a biopsy taken prior to the beginning of treatment.
What are the Neoadjuvant Chemotherapies?
- Adriamycin (Doxorubicin, Rubex, Lipodox, Caelyx, Myocet)
- Ellence (Epirubicin)
- Cyclophosphamide (Cytoxane)
- Platinol (Cisplatin, CDDP, Cisplatinum, Cis-diamminedichloroplatinum(II))
- Paraplatin (Carboplatin)
- Taxol (PTX, Paclitaxel)
- Taxotere (DTX. Docetaxel, Docefrez)
- Xeloda (Capecitabine)
- Gemzar (Gemcitabine)
- Otrexup, Rasuvo, Rheumatrex, Trexal, Amethopterin,( MTX, Methotrexate, Xatmep)
- Efudex or Fluoroplex (Fluorouracil, Adrucil, Tolak, Carac, 5-fluorouracil , 5-FU)
- Navelbine (NVB, Vinorelbine, Vinorelbine Tartrate
- Halaven (Eribuline)
- Ixempra (Ixabepilone)
Ready to Own Your Breast Cancer Journey?
- Complete the breast cancer questionnaire.
- Get your list of advanced breast cancer treatment options.
- Compare treatments of patients like you.
- Learn about the treatment or trial that’s right for you.
- Get the guidance you need.
BREAST CANCER COMMUNITY
Take back control
I have been thinking a lot about Control lately. How the second you get diagnosed you lose control over your life. It doesn’t matter if you are a control freak
CAR T Cell Therapy Talk
Did you miss Dr. Joshua Mansour’s webinar? You can view it anytime here. Dr. Joshua Mansour is a board certified hematologist and oncologist with additional training at Stanford in
Myelofibrosis News
Latest News in MF Cancer Research Myelofibrosis (MF) is a rare type of bone marrow cancer that disrupts normal production of blood cells. MF usually develops slowly, and initially